What is the Role of Biologics in UC?

Joanna K. Law, Brian Bressler

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.

Original languageEnglish (US)
Title of host publicationClinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition
PublisherWiley-Blackwell
Pages120-123
Number of pages4
ISBN (Print)9781444334548
DOIs
StatePublished - Jan 30 2012
Externally publishedYes

Fingerprint

Biological Products
Ulcerative Colitis
Mesalamine
Biological Therapy
Immunologic Factors
Colitis
Therapeutics
Adrenal Cortex Hormones

Keywords

  • Biologics
  • Infliximab
  • Ulcerative colitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Law, J. K., & Bressler, B. (2012). What is the Role of Biologics in UC? In Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition (pp. 120-123). Wiley-Blackwell. https://doi.org/10.1002/9781444342574.ch26

What is the Role of Biologics in UC? / Law, Joanna K.; Bressler, Brian.

Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell, 2012. p. 120-123.

Research output: Chapter in Book/Report/Conference proceedingChapter

Law, JK & Bressler, B 2012, What is the Role of Biologics in UC? in Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell, pp. 120-123. https://doi.org/10.1002/9781444342574.ch26
Law JK, Bressler B. What is the Role of Biologics in UC? In Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell. 2012. p. 120-123 https://doi.org/10.1002/9781444342574.ch26
Law, Joanna K. ; Bressler, Brian. / What is the Role of Biologics in UC?. Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition. Wiley-Blackwell, 2012. pp. 120-123
@inbook{e2b9f32439904c7faec47286709cb656,
title = "What is the Role of Biologics in UC?",
abstract = "The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.",
keywords = "Biologics, Infliximab, Ulcerative colitis",
author = "Law, {Joanna K.} and Brian Bressler",
year = "2012",
month = "1",
day = "30",
doi = "10.1002/9781444342574.ch26",
language = "English (US)",
isbn = "9781444334548",
pages = "120--123",
booktitle = "Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - What is the Role of Biologics in UC?

AU - Law, Joanna K.

AU - Bressler, Brian

PY - 2012/1/30

Y1 - 2012/1/30

N2 - The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.

AB - The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.

KW - Biologics

KW - Infliximab

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84885520642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885520642&partnerID=8YFLogxK

U2 - 10.1002/9781444342574.ch26

DO - 10.1002/9781444342574.ch26

M3 - Chapter

AN - SCOPUS:84885520642

SN - 9781444334548

SP - 120

EP - 123

BT - Clinical Dilemmas in Inflammatory Bowel Disease: New Challenges: Second Edition

PB - Wiley-Blackwell

ER -